<code id='D210F987C7'></code><style id='D210F987C7'></style>
      • <acronym id='D210F987C7'></acronym>
      <center id='D210F987C7'><center id='D210F987C7'><tfoot id='D210F987C7'></tfoot></center><abbr id='D210F987C7'><dir id='D210F987C7'><tfoot id='D210F987C7'></tfoot><noframes id='D210F987C7'>
      • <optgroup id='D210F987C7'><strike id='D210F987C7'><sup id='D210F987C7'></sup></strike><code id='D210F987C7'></code></optgroup>
        5. <b id='D210F987C7'><label id='D210F987C7'><select id='D210F987C7'><dt id='D210F987C7'><span id='D210F987C7'></span></dt></select></label></b><u id='D210F987C7'></u>
          <i id='D210F987C7'><strike id='D210F987C7'><tt id='D210F987C7'><pre id='D210F987C7'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / comprehensive / focus      
           
     
           
      
          focus 
           
      
           
      
           
       2025-09-28 08:29:07 
   
      
           
      
           
                        
          focus  
          
                                   
                 
                                      author：leisure time   
                                        
                                      
                                      Page View：23
                                  
                                    
          
                                   
          In this photo illustration, Farxiga, Xarelto, Entresto, and Eliquis are made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. These are 4 of 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. The other drugs include Jardiance, Enbrel, Januvia, Imbruvica, Stelara and Fiasp.
          Scott Olson/Getty Images
          WASHINGTON  — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.
          The offers will not be made public unless a manufacturer chooses to publicly disclose information about the talks, a senior administration official said. Companies have until March 2 to either accept the government’s offer or propose a counteroffer. The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends. 
          advertisement
          The negotiated prices won’t take effect until 2026. 
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Unmasking the 'centricity' illusion in clinical trials
                                
                            
          Next article：  
                                      
                                          Wildfire smoke exposes gaps in outdoor worker protections
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles